The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders

详细信息    查看全文

• 作者：Graham Cocks (1)
  Sarah Curran (2)
  Priya Gami (1)
  Dafe Uwanogho (1)
  Aaron R. Jeffries (1)
  Annie Kathuria (1)
  Walter Lucchesi (1)
  Victoria Wood (1)
  Rosemary Dixon (1)
  Caroline Ogilvie (3)
  Thomas Steckler (4)
  Jack Price (1)
  
• 关键词：Induced pluripotent stem cells ; Autism ; SHANK3
• 刊名：Psychopharmacology
• 出版年：2014
• 出版时间：March 2014
• 年：2014
• 卷：231
• 期：6
• 页码：1079-1088
• 全文大小：628 KB
• 参考文献：1. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bili膰 J, Pekarik V, Tiscornia G, Edel M, Bou茅 S, Izpis煤a Belmonte JC (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26(11):1276鈥?284 CrossRef
  2. Aasen T, Izpis煤a Belmonte JC (2010) Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc 5(2):371鈥?82 CrossRef
  3. Andrews PW, Meyer LJ, Bednarz KL, Harris H (1984) Two monoclonal antibodies recognizing determinants on human embryonal carcinoma cells react specifically with the liver isozyme of human alkaline phosphatase. Hybridoma 3(1):33鈥?9 CrossRef
  4. Anson BD, Kolaja KL, Kamp TJ (2011) Opportunities for use of human iPS cells in predictive toxicology. Clin Pharmacol Ther 89(5):754鈥?58 CrossRef
  5. Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Rutter M, Lantos P (1998) A clinicopathological study of autism. Brain 121(Pt 5):889鈥?05 CrossRef
  6. Baron-Cohen (2000) The amygdala theory of autism. Neurosci Biobehav Rev 1鈥?0
  7. Baudouin SJ, Gaudias J, Gerharz S, Hatstatt L, Zhou K, Punnakkal P, Tanaka KF, Spooren W, Hen R, De Zeeuw CI, Vogt K, Scheiffele P (2012) Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science 338(6103):128鈥?32 CrossRef
  8. Betancur C (2011) Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380:42鈥?7 CrossRef
  9. Bonaglia MC, Giorda R, Borgatti R, Felisari G, Gagliardi C, Selicorni A, Zuffardi O (2001) Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet 69(2):261鈥?68 CrossRef
  10. Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S et al (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature 1鈥?
  11. Buie, T., Campbell, D. B., Fuchs, G. J., Furuta, G. T., Levy, J., VandeWater, J., et al. (2010). Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report. / PEDIATRICS, / 125(Supplement), S1 S18. doi:10.1542/peds.2009-1878C
  12. Buxhoeveden DP, Semendeferi K, Buckwalter J, Schenker N, Switzer R, Courchesne E (2006) Reduced minicolumns in the frontal cortex of patients with autism. Neuropathol Appl Neurobiol 32(5):483鈥?91 CrossRef
  13. Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, Mitalipova M, Jaenisch R (2009) Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A 106(1):157鈥?62 CrossRef
  14. Carper RA, Moses P, Tigue ZD, Courchesne E (2002) Cerebral lobes in autism: early hyperplasia and abnormal age effects. NeuroImage 16(4):1038鈥?051 CrossRef
  15. Casanova MF, Buxhoeveden DP, Switala AE, Roy E (2002) Minicolumnar pathology in autism. Neurology 58(3):428鈥?32 CrossRef
  16. Casanova MF, El-Baz A, Vanbogaert E, Narahari P, Switala A (2010) A topographic study of minicolumnar core width by lamina comparison between autistic subjects and controls: possible minicolumnar disruption due to an anatomical element in-common to multiple laminae. Brain Pathol 20(2):451鈥?58 CrossRef
  17. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27(3):275鈥?80 CrossRef
  18. Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, Hartung O, Rho J, Ince TA, Daley GQ, Schlaeger TM (2009) Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27(11):1033鈥?037 CrossRef
  19. Courchesne E, Karns CM, Davis HR, Ziccardi R, Carper RA, Tigue ZD, Chisum HJ, Moses P, Pierce K, Lord C, Lincoln AJ, Pizzo S, Schreibman L, Haas RH, Akshoomoff NA, Courchesne RY (2001) Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 57(2):245鈥?54 CrossRef
  20. Crawley JN (2012) Translational animal models of autism and neurodevelopmental disorders. Dialogues Clin Neurosci 14(3):293鈥?05
  21. Daley GQ, Lensch MW, Jaenisch R, Meissner A, Plath K, Yamanaka S (2009) Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell 4(3):200鈥?01 CrossRef
  22. Devlin B, Scherer SW (2012) Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev 22(3):229鈥?37 CrossRef
  23. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckars盲ter H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Rog茅 B, H茅ron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T (2007) Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39(1):25鈥?7 CrossRef
  24. Durand CM, Perroy J, Loll F, Perrais D, Fagni L, Bourgeron T, Montcouquiol M, Sans N (2012) SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol Psychiatry 17(1):71鈥?4 CrossRef
  25. Eglen R, Reisine T (2011) Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening. Assay Drug Dev Technol 9(2):108鈥?24 CrossRef
  26. Ebert DH, Greenberg ME (2013) Activity-dependent neuronal signalling and autism spectrum disorder. Nature 493(7432):327鈥?37 CrossRef
  27. Eiraku M, Watanabe K, Matsuo-Takasaki M, Kawada M, Yonemura S, Matsumura M, Wataya T, Nishiyama A, Muguruma K, Sasai Y (2008) Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 3(5):519鈥?32 CrossRef
  28. Hampson DR, Gholizadeh S, Pacey LK (2012) Pathways to drug development for autism spectrum disorders. Clin Pharmacol Ther 91(2):189鈥?00 CrossRef
  29. Hayashi MK, Tang C, Verpelli C, Narayanan R, Stearns MH, Xu RM, Li H, Sala C, Hayashi Y (2009) The postsynaptic density proteins Homer and Shank form a polymeric network structure. Cell 137(1):159鈥?71 CrossRef
  30. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH (1980) Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19(1):245鈥?54 CrossRef
  31. Huett A, Leong JM, Podolsky DK, Xavier RJ (2009) The cytoskeletal scaffold Shank3 is recruited to pathogen-induced actin rearrangements. Exp Cell Res 315(12):2001鈥?011 CrossRef
  32. Jeffries AR, Curran S, Elmslie F, Sharma A, Wenger S, Hummel M, Powell J (2005) Molecular and phenotypic characterization of ring chromosome 22. Am J Med Genet A 137(2):139鈥?47 CrossRef
  33. Jiang YH, Ehlers MD (2013) Modelling autism by SHANK gene mutations in mice. Neuron 78(1):8鈥?7 CrossRef
  34. Krueger DD, Bear MF (2011) Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 62:411鈥?29 CrossRef
  35. Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, Schopler E (1989) Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 19(2):185鈥?12 CrossRef
  36. Lord C, Rutter M, Le Couteur A (1994) Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24(5):659鈥?85 CrossRef
  37. Maherali N, Hochedlinger K (2008) Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3(6):595鈥?05 CrossRef
  38. Marchetto MC, Gage FH (2012) Modelling brain disease in a dish: really? Cell Stem Cell 10(6):642鈥?45 CrossRef
  39. Markou A, Chiamulera C, Geyer MA, Tricklebank M, Steckler T (2009) Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology 34(1):74鈥?9 CrossRef
  40. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D鈥橲ouza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, Turecki G, Delaney A, Varhol R, Thiessen N, Shchors K, Heine VM, Rowitch DH, Xing X, Fiore C, Schillebeeckx M, Jones SJ, Haussler D, Marra MA, Hirst M, Wang T, Costello JF (2010) Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466(7303):253鈥?57 CrossRef
  41. McAllister AK, Patterson PH (2012) Introduction to special issue on neuroimmunology in brain development and disease. Dev Neurobiol 72(10):1269鈥?271 CrossRef
  42. Muguruma K, Nishiyama A, Ono Y, Miyawaki H, Mizuhara E, Hori S, Kakizuka A, Obata K, Yanagawa Y, Hirano T, Sasai Y (2010) Ontogeny-recapitulating generation and tissue integration of ES cell-derived Purkinje cells. Nat Neurosci 13(10):1171鈥?180 CrossRef
  43. M眉ller FJ, Goldmann J, L枚ser P, Loring JF (2010) A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell 6(5):412鈥?14 CrossRef
  44. M眉ller FJ, Schuldt BM, Williams R, Mason D, Altun G, Papapetrou EP, Danner S, Goldmann JE, Herbst A, Schmidt NO, Aldenhoff JB, Laurent LC, Loring JF (2011) A bioinformatic assay for pluripotency in human cells. Nat Methods 8(4):315鈥?17 CrossRef
  45. Nasu M, Takata N, Danjo T, Sakaguchi H, Kadoshima T, Futaki S, Sekiguchi K, Eiraku M, Sasai Y (2012) Robust formation and maintenance of continuous stratified cortical neuroepithelium by laminin-containing matrix in mouse ES cell culture. PLoS One 7(12):e53024 CrossRef
  46. Nightingale S (2012) Autism spectrum disorders. Nat Rev Drug Discov 11(10):745鈥?46 CrossRef
  47. Nishimura K, Sano M, Ohtaka M, Furuta B, Umemura Y, Nakajima Y et al (2011) Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem 286(6):4760鈥?771 CrossRef
  48. Palmen SJ, van Engeland H, Hof PR, Schmitz C (2004) Neuropathological findings in autism. Brain 127(Pt 12):2572鈥?583 CrossRef
  49. Pankratz MT, Li XJ, Lavaute TM, Lyons EA, Chen X, Zhang SC (2007) Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 25(6):1511鈥?520 CrossRef
  50. Papapetrou EP, Sadelain M (2011) Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector. Nat Protoc 6(9):1251鈥?273 CrossRef
  51. Pa艧ca SP, Portmann T, Voineagu I, Yazawa M, Shcheglovitov A, Pa艧ca AM et al (2011) Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Publ Group 17(12):1657鈥?662
  52. Phelan K, McDermid HE (2012) The 22q13.3 deletion syndrome (Phelan鈥揗cDermid syndrome). Mol Syndromol 2(3鈥?):186鈥?01
  53. Redcay E, Courchesne E (2005) When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry 58(1):1鈥? CrossRef
  54. Redecker P, Bockmann J, B枚ckers TM (2006) Expression of postsynaptic density proteins of the ProSAP/Shank family in the thymus. Histochem Cell Biol 126(6):679鈥?85 CrossRef
  55. Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H, Guthrie D, Ritvo A (1986) Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. Am J Psychiatry 143(7):862鈥?66
  56. Roullet FI, Lai JK, Foster JA. In utero exposure to valproic acid and autism - A current review of clinical and animal studies. Neurotoxicol Teratol. 2013 Feb 8 [Epub ahead of print]
  57. Roussignol G, Ango F, Romorini S, Tu JC, Sala C, Worley PF, Bockaert J, Fagni L (2005) Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J Neurosci 25(14):3560鈥?570 CrossRef
  58. Sasai Y (2013) Cytosystems dynamics in self-organization of tissue architecture. Nature 493(7432):318鈥?26 CrossRef
  59. Shi Y, Kirwan P, Smith J, Robinson HP, Livesey FJ (2012) Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat Neurosci 15(3):477鈥?86 CrossRef
  60. Sparks BF, Friedman SD, Shaw DW, Aylward EH, Echelard D, Artru AA, Maravilla KR, Giedd JN, Munson J, Dawson G, Dager SR (2002) Brain structural abnormalities in young children with autism spectrum disorder. Neurology 59(2):184鈥?92 CrossRef
  61. St John JC, Armstrong L, Minger SL, Campbell KH (2008) Law should recognize value of interspecies embryos. Nature 451(7179):627 CrossRef
  62. Su HL, Muguruma K, Matsuo-Takasaki M, Kengaku M, Watanabe K, Sasai Y (2006) Generation of cerebellar neuron precursors from embryonic stem cells. Dev Biol 290(2):287鈥?96 CrossRef
  63. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663鈥?76 CrossRef
  64. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861鈥?72 CrossRef
  65. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145鈥?147 CrossRef
  66. van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O鈥機ollins V, Macleod MR (2010) Can animal models of disease reliably inform human studies? PLoS Med 30:7(3)
  67. Verpelli C, Schmeisser MJ, Sala C, Boeckers TM (2012) Scaffold proteins at the postsynaptic density. Adv Exp Med Biol 970:29鈥?1 CrossRef
  68. Verpelli C, Dvoretskova E, Vicidomini C, Rossi F, Chiappalone M, Schoen M, Di Stefano B, Mantegazza R, Broccoli V, B枚ckers TM, Dityatev A, Sala C (2011) Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. J Biol Chem 286(40):34839鈥?4850 CrossRef
  69. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5):618鈥?30 CrossRef
  70. Whitney ER, Kemper TL, Bauman ML, Rosene DL, Blatt GJ (2008) Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin-D28k. Cerebellum 7(3):406鈥?16 CrossRef
  71. Wilson HL, Wong AC, Shaw SR, Tse WY, Stapleton GA, Phelan MC, Hu S, Marshall J, McDermid HE (2003) Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 40(8):575鈥?84 CrossRef
  72. Yang YM (2013) A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell S1934-5909(13):00139鈥?. doi:10.1016/j.stem.2013.04.003
  73. Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, Spivak JL, Moliterno AR, Cheng L (2009) Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114(27):5473鈥?480 CrossRef
  74. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324(5928):797鈥?01 CrossRef
  75. Zhu S, Li W, Zhou H, Wei W, Ambasudhan R, Lin T, Kim J, Zhang K, Ding S (2010) Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7(6):651鈥?55 CrossRef
  
• 作者单位：Graham Cocks (1)
  Sarah Curran (2)
  Priya Gami (1)
  Dafe Uwanogho (1)
  Aaron R. Jeffries (1)
  Annie Kathuria (1)
  Walter Lucchesi (1)
  Victoria Wood (1)
  Rosemary Dixon (1)
  Caroline Ogilvie (3)
  Thomas Steckler (4)
  Jack Price (1)
  
  1. Department of Neuroscience, The James Black Centre, King鈥檚 College London, 125 Coldharbour lane, London, UK
  2. Child and Adolescent Psychiatry Department and MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, London, UK
  3. Guy鈥檚 and St. Thomas鈥?Centre for Pre-implantation Genetic Diagnosis and Genetics Centre, Guy鈥檚 and St. Thomas鈥?NHS Foundation Trust, London, UK
  4. Neuroscience Discovery, Janssen Research and Development, Beerse, Belgium
  
• ISSN：1432-2072

文摘

Until now, models of psychiatric diseases have typically been animal models. Whether they were to be used to further understand the pathophysiology of the disorder, or as drug discovery tools, animal models have been the choice of preference in mimicking psychiatric disorders in an experimental setting. While there have been cellular models, they have generally been lacking in validity. This situation is changing with the advent of patient-specific induced pluripotent stem cells (iPSCs). In this article, we give a methodological evaluation of the current state of the iPS technology with reference to our own work in generating patient-specific iPSCs for the study of autistic spectrum disorder (ASD). In addition, we will give a broader perspective on the validity of this technology and to what extent it can be expected to complement animal models of ASD in the coming years.